NCT06472999 Nephroprotective Measures in Critically Ill Patients With Moderate/Severe Acute Kidney Injury
| NCT ID | NCT06472999 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universität Münster |
| Condition | Acute Kidney Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 257 participants |
| Start Date | 2024-07-24 |
| Primary Completion | 2025-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 257 participants in total. It began in 2024-07-24 with a primary completion date of 2025-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates to which extent recommended nephroprotective measures are implemented in critically ill patients with moderate or severe acute kidney injury.
Eligibility Criteria
Inclusion Criteria: 1. Critically ill patients with moderate or severe AKI (KDIGO stage 2 / 3) 2. Requirement of vasopressors or mechanical ventilation 3. Age ≥ 18 years 4. Informed consent Exclusion Criteria: 1. Chronic kidney disease (CKD) with a glomerular filtration rate \< 20ml/min 2. Chronic dialysis dependency 3. History of renal transplantation 4. Permanent ligation of the renal arteries 5. AKI immediately following nephrectomy 6. Patients requiring permanent administration of nephrotoxic drugs (e.g. immunosuppressive therapy afer liver transplantation) 7. Persons with any kind of dependency on the investigator or employed by the sponsor or investigator.
Contact & Investigator
Alexander Zarbock, MD
PRINCIPAL INVESTIGATOR
University Münster
Frequently Asked Questions
Who can join the NCT06472999 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Kidney Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06472999 currently recruiting?
Yes, NCT06472999 is actively recruiting participants. Contact the research team at meersch@uni-muenster.de for enrollment information.
Where is the NCT06472999 trial being conducted?
This trial is being conducted at Innsbruck, Austria, Münster, Germany, Nijmegen, Netherlands.
Who is sponsoring the NCT06472999 clinical trial?
NCT06472999 is sponsored by Universität Münster. The principal investigator is Alexander Zarbock, MD at University Münster. The trial plans to enroll 257 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.